Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor Presentation

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Mid-range Performer

1971.7000 -59.00 (-2.91%)

NSE Sep 26, 2025 15:31 PM

54.58% Gain from 52W Low

Volume: 924.5K

Glenmark Pharmaceuticals Ltd.

23 May 2025

1971.70

-2.91%

Investor Presentation

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation Q4, F.Y. 2024-25

More from Glenmark Pharmace…

All earning calls

Investor presentations from Glenmark Pharmace…

All investor presentations